Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIOGEN | 8 | 54 | -0,01 % | ||
| BIONTECH | 8 | 13 | -0,06 % | ||
| COMPASS PATHWAYS | 6 | 11 | 0,00 % | ||
| ANI PHARMACEUTICALS | 5 | 5 | 0,00 % | ||
| BRIDGEBIO PHARMA | 5 | - | -0,20 % | ||
| LEGEND BIOTECH | 5 | - | -2,80 % | ||
| ANAPTYSBIO | 4 | 2 | -3,06 % | ||
| ATAIBECKLEY | 4 | - | +2,40 % | ||
| AMGEN | 3 | 27 | +0,27 % | ||
| GILEAD SCIENCES | 3 | 5 | -0,31 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05:10 | Nahost-Konflikt belastet Märkte: Food-Lieferketten werden zum Schlüsselthema - MustGrow, K+S, Evotec und BioNTech im Fokus | 407 | inv3st.de | Der Nahost-Konflikt rückt die globalen Lieferketten erneut in den Fokus und erhöht den Druck auf sensible Versorgungswege. Besonders die Straße von Hormus bleibt dabei ein zentraler geopolitischer Risikofaktor... ► Artikel lesen | |
| 00:27 | Why Legend Biotech Stock Crushed the Market on Monday | 2 | The Motley Fool | ||
| 00:26 | Jefferies Initiates Coverage of Caris Life Sciences Inc. (CAI) With a Buy Rating | 2 | Insider Monkey | ||
| Mo | FDA grants fast track status to BridgeBio's pancreatic cancer drug | 2 | Investing.com | ||
| Mo | ANAPTYSBIO, INC - 8-K, Current Report | - | SEC Filings | ||
| Mo | Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 7 | GlobeNewswire (USA) | ||
| Mo | Trevi Therapeutics, Inc.: Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares | 4 | GlobeNewswire (USA) | ||
| Mo | EQS-News: ABIVAX: Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents | 278 | EQS Group (EN) | EQS-News: ABIVAX
/ Key word(s): AGM/EGM
Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents
20.04.2026 /... ► Artikel lesen | |
| Mo | Cytokinetics, Incorporated: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) | 4 | GlobeNewswire (USA) | ||
| Mo | Leerink senkt Kursziel für Arcus Biosciences nach Ende der Gilead-Kooperation | 14 | Investing.com Deutsch | ||
| Mo | Leerink cuts Arcus Biosciences stock price target on Gilead collaboration end | 2 | Investing.com | ||
| Mo | AACR: Endeavoring to go global, Zai Lab offers reality check on China's biotech ascent | 1 | FierceBiotech | ||
| Mo | Abivax S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| Mo | Trump Sends Compass Pathways Stock Soaring as He Backs Psychedelics. Should You Buy CMPS Here? | 4 | Barchart.com | ||
| Mo | Kyverna rises on new mid-stage trial data for myasthenia gravis therapy | 10 | Seeking Alpha | ||
| Mo | AnaptysBio rises after completing First Tracks spinoff | 6 | Seeking Alpha | ||
| Mo | Here's Why Agios Pharmaceuticals Crashed 23% Today | 8 | The Motley Fool | ||
| Mo | Stifel reiterates Tango Therapeutics stock rating on combo potential | 1 | Investing.com | ||
| Mo | Stifel bestätigt Kaufempfehlung für Tango Therapeutics wegen Kombinationspotenzial | 9 | Investing.com Deutsch | ||
| Mo | Biogen Earnings Preview: What to Expect | 5 | Barchart.com |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.